393 related articles for article (PubMed ID: 33223752)
1. Tim-3 promotes cell aggressiveness and paclitaxel resistance through NF-κB/STAT3 signalling pathway in breast cancer cells.
Cong Y; Cui Y; Zhu S; Cao J; Zou H; Martin TA; Qiao G; Jiang W; Yu Z
Chin J Cancer Res; 2020 Oct; 32(5):564-579. PubMed ID: 33223752
[TBL] [Abstract][Full Text] [Related]
2. Tim-3 promotes tube formation and decreases tight junction formation in vascular endothelial cells.
Cong Y; Wang X; Wang S; Qiao G; Li Y; Cao J; Jiang W; Cui Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015716
[TBL] [Abstract][Full Text] [Related]
3. AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K/AKT/NF-κB signaling pathway.
Qu J; Li J; Zhang Y; He R; Liu X; Gong K; Duan L; Luo W; Hu Z; Wang G; Xia C; Luo D
Cell Biosci; 2021 Aug; 11(1):163. PubMed ID: 34419144
[TBL] [Abstract][Full Text] [Related]
4. Expression of Tim-3 in breast cancer tissue promotes tumor progression.
Cheng S; Han F; Xu Y; Qu T; Ju Y
Int J Clin Exp Pathol; 2018; 11(3):1157-1166. PubMed ID: 31938210
[TBL] [Abstract][Full Text] [Related]
5. Targeting STAT3 Abrogates Tim-3 Upregulation of Adaptive Resistance to PD-1 Blockade on Regulatory T Cells of Melanoma.
Huang L; Xu Y; Fang J; Liu W; Chen J; Liu Z; Xu Q
Front Immunol; 2021; 12():654749. PubMed ID: 33936081
[TBL] [Abstract][Full Text] [Related]
6. Tumor cell-intrinsic Tim-3 promotes liver cancer via NF-κB/IL-6/STAT3 axis.
Zhang H; Song Y; Yang H; Liu Z; Gao L; Liang X; Ma C
Oncogene; 2018 May; 37(18):2456-2468. PubMed ID: 29449693
[TBL] [Abstract][Full Text] [Related]
7. IL-6 promotes metastasis of non-small-cell lung cancer by up-regulating TIM-4 via NF-κB.
Liu W; Wang H; Bai F; Ding L; Huang Y; Lu C; Chen S; Li C; Yue X; Liang X; Ma C; Xu L; Gao L
Cell Prolif; 2020 Mar; 53(3):e12776. PubMed ID: 32020709
[TBL] [Abstract][Full Text] [Related]
8. Endothelial cell-expressed Tim-3 facilitates metastasis of melanoma cells by activating the NF-kappaB pathway.
Wu FH; Yuan Y; Li D; Lei Z; Song CW; Liu YY; Li B; Huang B; Feng ZH; Zhang GM
Oncol Rep; 2010 Sep; 24(3):693-9. PubMed ID: 20664975
[TBL] [Abstract][Full Text] [Related]
9. Higher T cell immunoglobulin mucin-3 (Tim-3) expression in cervical cancer is associated with a satisfactory prognosis.
Wang Y; Zhao S; Zhang X; Zhu H; Ji X; Jiang Y; Meng J; Shi H; Gao X; Zhang X; Li H
Transl Cancer Res; 2020 Apr; 9(4):2801-2813. PubMed ID: 35117637
[TBL] [Abstract][Full Text] [Related]
10. TIMELESS contributes to the progression of breast cancer through activation of MYC.
Chi L; Zou Y; Qin L; Ma W; Hao Y; Tang Y; Luo R; Wu Z
Breast Cancer Res; 2017 May; 19(1):53. PubMed ID: 28464854
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Impact of PD-1 and Tim-3 Expression in Tumor Tissue in Stage I-III Colorectal Cancer.
Kuai W; Xu X; Yan J; Zhao W; Li Y; Wang B; Yuan N; Li Z; Jia Y
Biomed Res Int; 2020; 2020():5294043. PubMed ID: 32509862
[TBL] [Abstract][Full Text] [Related]
12. TIM-3 Participates in the Invasion and Metastasis of Nasopharyngeal Carcinoma via SMAD7/SMAD2/SNAIL1 Axis-Mediated Epithelial-Mesenchymal Transition.
Xiao Y; Qing J; Li B; Chen L; Nong S; Yang W; Tang X; Chen Z
Onco Targets Ther; 2020; 13():1993-2006. PubMed ID: 32184631
[TBL] [Abstract][Full Text] [Related]
13. TIM-3 as a Prognostic Marker and a Potential Immunotherapy Target in Human Malignant Tumors: A Meta-Analysis and Bioinformatics Validation.
Zang K; Hui L; Wang M; Huang Y; Zhu X; Yao B
Front Oncol; 2021; 11():579351. PubMed ID: 33692946
[TBL] [Abstract][Full Text] [Related]
14. T-Cell Immunoglobulin Mucin 3 Expression on Tumor Infiltrating Lymphocytes as a Positive Prognosticator in Triple-Negative Breast Cancer.
Byun KD; Hwang HJ; Park KJ; Kim MC; Cho SH; Ju MH; Lee JH; Jeong JS
J Breast Cancer; 2018 Dec; 21(4):406-414. PubMed ID: 30607162
[TBL] [Abstract][Full Text] [Related]
15. The Emerging Role of T-Cell Immunoglobulin Mucin-3 in Breast Cancer: A Promising Target For Immunotherapy.
Cong Y; Liu J; Chen G; Qiao G
Front Oncol; 2021; 11():723238. PubMed ID: 34504800
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the expression levels of T-cell immunoglobulin mucin-3 and its ligand galectin-9 for relapse-free survival in triple-negative breast cancer.
Yoshikawa K; Ishida M; Yanai H; Tsuta K; Sekimoto M; Sugie T
Oncol Lett; 2022 Jun; 23(6):197. PubMed ID: 35572493
[TBL] [Abstract][Full Text] [Related]
17. miR-423 Promotes Breast Cancer Invasion by Activating NF-κB Signaling.
Dai T; Zhao X; Li Y; Yu L; Li Y; Zhou X; Gong Q
Onco Targets Ther; 2020; 13():5467-5478. PubMed ID: 32606763
[TBL] [Abstract][Full Text] [Related]
18. [Expression and distribution of programmed death receptor 1 and T cell immunoglobulin mucin 3 in breast cancer microenvironment and its relationship with clinicopathological features].
Shen H; Sheng H; Lu JJ; Feng C; Yao M; Pan H; Xu LS; Shen JF; Zheng Y; Zhou YL
Zhonghua Yi Xue Za Zhi; 2018 May; 98(17):1352-1357. PubMed ID: 29764038
[No Abstract] [Full Text] [Related]
19. Tim-3 exacerbates kidney ischaemia/reperfusion injury through the TLR-4/NF-κB signalling pathway and an NLR-C4 inflammasome activation.
Guo Y; Zhang J; Lai X; Chen M; Guo Y
Clin Exp Immunol; 2018 Jul; 193(1):113-129. PubMed ID: 29570768
[TBL] [Abstract][Full Text] [Related]
20. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
